{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:11:51Z","timestamp":1791270711229,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ghir.2013.03.004","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T23:06:06Z","timestamp":1366153566000},"page":"53-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["The role of insulin-like-growth factor binding protein 2 (IGFBP2) and phosphatase and tensin homologue (PTEN) in the regulation of myoblast differentiation and hypertrophy"],"prefix":"10.1016","volume":"23","author":[{"given":"Adam P.","family":"Sharples","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser","family":"Al-Shanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ghir.2013.03.004_bb0005","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/jcp.22252","article-title":"C2 and C2C12 murine skeletal myoblast models of atrophic and hypertrophic potential: relevance to disease and ageing?","volume":"225","author":"Sharples","year":"2010","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.ghir.2013.03.004_bb0010","first-page":"607","article-title":"Gene expression and secretion of insulin-like growth factor-binding proteins during myoblast differentiation","volume":"130","author":"Ernst","year":"1992","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.ghir.2013.03.004_bb0015","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/er.2001-0033","article-title":"Cellular actions of the insulin-like growth factor binding proteins","volume":"23","author":"Firth","year":"2002","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.ghir.2013.03.004_bb0020","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/endo.142.5.8149","article-title":"Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2","volume":"142","author":"Hoeflich","year":"2001","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.ghir.2013.03.004_bb0025","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.ghir.2013.03.004_bb0030","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0889-8529(05)70342-X","article-title":"The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action","volume":"25","author":"Collett-Solberg","year":"1996","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"11\u201312","key":"10.1016\/j.ghir.2013.03.004_bb0035","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0898-6568(00)00120-0","article-title":"Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase","volume":"12","author":"Li","year":"2000","journal-title":"Cell. Signal."},{"issue":"32","key":"10.1016\/j.ghir.2013.03.004_bb0040","doi-asserted-by":"crossref","first-page":"19146","DOI":"10.1074\/jbc.271.32.19146","article-title":"Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells","volume":"271","author":"Kaliman","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ghir.2013.03.004_bb0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.yexcr.2003.10.034","article-title":"Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: roles of IGF-I and TNFalpha","volume":"294","author":"Foulstone","year":"2004","journal-title":"Exp. Cell Res."},{"issue":"10","key":"10.1016\/j.ghir.2013.03.004_bb0050","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1074\/jbc.272.10.6653","article-title":"The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways","volume":"272","author":"Coolican","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ghir.2013.03.004_bb0055","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1073\/pnas.93.6.2482","article-title":"Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor","volume":"93","author":"Jones","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.ghir.2013.03.004_bb0060","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1210\/en.2005-0467","article-title":"Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion","volume":"146","author":"Russo","year":"2005","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.ghir.2013.03.004_bb0065","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1002\/j.1460-2075.1989.tb08386.x","article-title":"Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2)","volume":"8","author":"Binkert","year":"1989","journal-title":"EMBO J."},{"issue":"Pt. 22","key":"10.1016\/j.ghir.2013.03.004_bb0070","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1242\/jcs.00097","article-title":"Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin","volume":"115","author":"McCaig","year":"2002","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.ghir.2013.03.004_bb0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(00)81780-8","article-title":"Negative regulation of PKB\/Akt-dependent cell survival by the tumor suppressor PTEN","volume":"95","author":"Stambolic","year":"1998","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ghir.2013.03.004_bb0080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tem.2009.01.002","article-title":"IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis","volume":"20","author":"Wheatcroft","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"issue":"22","key":"10.1016\/j.ghir.2013.03.004_bb0085","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.1074\/jbc.273.22.13375","article-title":"The tumor suppressor, PTEN\/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate","volume":"273","author":"Maehama","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.ghir.2013.03.004_bb0090","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/hmg\/11.15.1687","article-title":"PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway","volume":"11","author":"Weng","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"13","key":"10.1016\/j.ghir.2013.03.004_bb0095","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1073\/pnas.0609139104","article-title":"Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K\/Akt pathway activation in glioblastoma and prostate cancer","volume":"104","author":"Mehrian-Shai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ghir.2013.03.004_bb0100","first-page":"1152","article-title":"Increased fat mass, decreased myofiber size, and a shift to glycolytic muscle metabolism in adolescent male transgenic mice overexpressing IGFBP-2","volume":"10","author":"Rehfeldt","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ghir.2013.03.004_bb0105","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1210\/en.2007-1068","article-title":"Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice","volume":"149","author":"DeMambro","year":"2008","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.ghir.2013.03.004_bb0110","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cytogfr.2006.09.006","article-title":"Waste management \u2014 cytokines, growth factors and cachexia","volume":"17","author":"Saini","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.ghir.2013.03.004_bb0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/MOG.0b013e3283347e77","article-title":"Cancer cachexia","volume":"26","author":"Tisdale","year":"2009","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"5","key":"10.1016\/j.ghir.2013.03.004_bb0120","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1468-1293.2006.00380.x","article-title":"Counteracting muscle wasting in HIV-infected individuals","volume":"7","author":"Dudgeon","year":"2006","journal-title":"HIV Med."},{"key":"10.1016\/j.ghir.2013.03.004_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2741\/2682","article-title":"Heart failure and cachexia: insights offered from molecular biology","volume":"13","author":"Conraads","year":"2008","journal-title":"Front. Biosci."},{"issue":"10","key":"10.1016\/j.ghir.2013.03.004_bb0130","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.biocel.2005.01.017","article-title":"Novel aspects on the regulation of muscle wasting in sepsis","volume":"37","author":"Hasselgren","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"12","key":"10.1016\/j.ghir.2013.03.004_bb0135","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1002\/jcb.23308","article-title":"Reduction of myoblast differentiation following multiple population doublings in mouse C(2) C(12) cells: a model to investigate ageing?","volume":"112","author":"Sharples","year":"2011","journal-title":"J. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.ghir.2013.03.004_bb0140","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.exger.2009.05.002","article-title":"Molecular basis of the myogenic profile of aged human skeletal muscle satellite cells during differentiation","volume":"44","author":"Pietrangelo","year":"2009","journal-title":"Exp. Gerontol."},{"issue":"3","key":"10.1016\/j.ghir.2013.03.004_bb0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/BC20070085","article-title":"Replicative aging down-regulates the myogenic regulatory factors in human myoblasts","volume":"100","author":"Bigot","year":"2008","journal-title":"Biol. Cell"},{"issue":"3","key":"10.1016\/j.ghir.2013.03.004_bb0150","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1113\/expphysiol.2011.061028","article-title":"Sirtuin 1 regulates skeletal myoblast survival and enhances differentiation in the presence of resveratrol","volume":"97","author":"Saini","year":"2012","journal-title":"Exp. Physiol."},{"issue":"1","key":"10.1016\/j.ghir.2013.03.004_bb0155","doi-asserted-by":"crossref","DOI":"10.1089\/rej.2007.0588","article-title":"Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation","volume":"11","author":"Leger","year":"2008","journal-title":"Rejuvenation Res."},{"issue":"3","key":"10.1016\/j.ghir.2013.03.004_bb0160","first-page":"230","article-title":"Myoblast models of skeletal muscle hypertrophy and atrophy","volume":"14","author":"Sharples","year":"2011","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"4727","key":"10.1016\/j.ghir.2013.03.004_bb0165","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1126\/science.2414846","article-title":"Plasticity of the differentiated state","volume":"230","author":"Blau","year":"1985","journal-title":"Science"},{"issue":"5639","key":"10.1016\/j.ghir.2013.03.004_bb0170","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/270725a0","article-title":"Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle","volume":"270","author":"Yaffe","year":"1977","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.ghir.2013.03.004_bb0175","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jim.2009.08.015","article-title":"Simultaneous detection of ERK-, p38-, and JNK-MAPK phosphorylation in human adipose-derived stem cells using the Cytometric Bead Array technology","volume":"350","author":"Schubert","year":"2009","journal-title":"J. Immunol. Methods"},{"issue":"2","key":"10.1016\/j.ghir.2013.03.004_bb0180","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.pain.2010.07.018","article-title":"Mechanisms involved in IL-6-induced muscular mechanical hyperalgesia in mice","volume":"151","author":"Manjavachi","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.ghir.2013.03.004_bb0185","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1756-0500-3-53","article-title":"Detection of siRNA induced mRNA silencing by RT-qPCR: considerations for experimental design","volume":"3","author":"Holmes","year":"2010","journal-title":"BMC Res. Notes"},{"issue":"6","key":"10.1016\/j.ghir.2013.03.004_bb0190","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"issue":"9","key":"10.1016\/j.ghir.2013.03.004_bb0195","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.freeradbiomed.2012.08.566","article-title":"Redox control of cytosolic Akt phosphorylation in PTEN null cells","volume":"53","author":"Luo","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.ghir.2013.03.004_bb0200","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1677\/JOE-08-0151","article-title":"PD98059 enhances C2 myoblast differentiation through p38 MAPK activation: a novel role for PD98059","volume":"198","author":"Al-Shanti","year":"2008","journal-title":"J. Endocrinol."},{"issue":"4","key":"10.1016\/j.ghir.2013.03.004_bb0205","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/08977191003745472","article-title":"IGFBP-2 expression in MCF-7 cells is regulated by the PI3K\/AKT\/mTOR pathway through Sp1-induced increase in transcription","volume":"28","author":"Mireuta","year":"2010","journal-title":"Growth Factors"},{"key":"10.1016\/j.ghir.2013.03.004_bb0215","first-page":"376","article-title":"Overexpression of IGFBP-2 in transgenic mice affects muscle protein accretion, skeletal myofibre growth and metabolism","volume":"16","author":"Rehfeldt","year":"2008","journal-title":"Endocr. Abstr."},{"issue":"3","key":"10.1016\/j.ghir.2013.03.004_bb0220","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1083\/jcb.133.3.683","article-title":"Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism","volume":"133","author":"James","year":"1996","journal-title":"J. Cell Biol."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109663741300021X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109663741300021X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:47:40Z","timestamp":1761086860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109663741300021X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S109663741300021X"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2013.03.004","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of insulin-like-growth factor binding protein 2 (IGFBP2) and phosphatase and tensin homologue (PTEN) in the regulation of myoblast differentiation and hypertrophy","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2013.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}